beta-alanine has been researched along with Thrombopenia in 6 studies
Excerpt | Relevance | Reference |
---|---|---|
"To present a case of dabigatran use for nonvalvular atrial fibrillation in a patient from a population for whom it has not been studied." | 7.78 | Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies. ( Fieland, D; Taylor, M, 2012) |
"To present a case of dabigatran use for nonvalvular atrial fibrillation in a patient from a population for whom it has not been studied." | 3.78 | Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies. ( Fieland, D; Taylor, M, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takami, H | 1 |
Oshiro, N | 1 |
Hiraoka, F | 1 |
Murao, M | 1 |
Ide, T | 1 |
Krauel, K | 1 |
Hackbarth, C | 1 |
Fürll, B | 1 |
Greinacher, A | 1 |
Fieland, D | 1 |
Taylor, M | 1 |
Bilen, O | 1 |
Teruya, J | 1 |
Bednar, B | 1 |
Cook, JJ | 1 |
Holahan, MA | 1 |
Cunningham, ME | 1 |
Jumes, PA | 1 |
Bednar, RA | 1 |
Hartman, GD | 1 |
Gould, RJ | 1 |
Vermes, A | 1 |
Guchelaar, HJ | 1 |
van Kuilenburg, AB | 1 |
Dankert, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Pilot Study to Evaluate the Safety and Preliminary Evidence of an Effect of ODSH (2 O, 3-O Desulfated Heparin) in Accelerating Platelet Recovery in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia[NCT02056782] | Phase 1 | 12 participants (Actual) | Interventional | 2013-12-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"A secondary endpoint of this study was to determine whether there was preliminary evidence of an effect of dociparstat on remission rate following cytarabine and idarubicin induction in acute myeloid leukemia (AML) patients, which included complete remission (CR) rate (with neutrophil and platelet count recovery) after the first induction cycle.~Morphologic CR was defined as absolute neutrophil count (ANC) >1000/μL, platelet count >100,000/μL, <5% bone marrow blasts, no Auer rods, and no evidence of extramedullary disease." (NCT02056782)
Timeframe: Day 1 to Day 35 (35 days)
Intervention | Participants (Count of Participants) |
---|---|
Dociparstat | 11 |
A primary endpoint of this study was evidence of an effect of dociparstat on transfusion independent platelet recovery time. The time (days) to transfusion-independent platelet recovery will be defined as the number of days from the first day of chemotherapy until the first of 5 consecutive days with platelet counts values ≥ 20,000/μL and ≥ 50,000/μL without a platelet transfusion. (NCT02056782)
Timeframe: Day 1 to Day 35 (35 days)
Intervention | days (Mean) | |
---|---|---|
Platelet count of ≥20,000/µL | Platelet count of ≥50,000/µL | |
Dociparstat | 21.3 | 23.1 |
1 review available for beta-alanine and Thrombopenia
Article | Year |
---|---|
Complications of anticoagulation.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Contamination; | 2012 |
1 trial available for beta-alanine and Thrombopenia
Article | Year |
---|---|
5-fluorocytosine-related bone-marrow depression and conversion to fluorouracil: a pilot study.
Topics: Adult; Aged; beta-Alanine; Biotransformation; Bone Marrow; Candidiasis; Female; Flucytosine; Fluorou | 2002 |
4 other studies available for beta-alanine and Thrombopenia
Article | Year |
---|---|
Rapid resolution of a spontaneous large chronic subdural haematoma in the posterior fossa under conservative treatment with platelet administration to aplastic anaemia.
Topics: Aged, 80 and over; Anemia, Aplastic; Anticoagulants; Benzimidazoles; beta-Alanine; Cranial Fossa, Po | 2013 |
Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
Topics: Antibodies; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Cells; Cells, Cultured; Dabigatran; | 2012 |
Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coronary Artery Bypass; Dabi | 2012 |
Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azepines; beta-Alanine; Blood Platelets; Disease Susce | 1999 |